Format

Send to

Choose Destination
BMC Cancer. 2006 Oct 26;6:256.

High Smac/DIABLO expression is associated with early local recurrence of cervical cancer.

Author information

1
Subdirección de Investigación Básica, Instituto Nacional de Cancerología, Av, San Fernando # 22, Tlalpan 14080 México City, Mexico. abrilarellano@gmail.com <abrilarellano@gmail.com>

Abstract

BACKGROUND:

In a recent pilot report, we showed that Smac/DIABLO mRNA is expressed de novo in a subset of cervical cancer patients. We have now expanded this study and analyzed Smac/DIABLO expression in the primary lesions in 109 cervical cancer patients.

METHODS:

We used immunohistochemistry of formalin-fixed, paraffin-embedded tissue sections to analyze Smac/DIABLO expression in the 109 primary lesions. Seventy-eight samples corresponded to epidermoid cervical cancer and 31 to cervical adenocarcinoma. The median follow up was 46.86 months (range 10-186).

RESULTS:

Smac/DIABLO was expressed in more adenocarcinoma samples than squamous tumours (71% vs 50%; p = 0.037). Among the pathological variables, a positive correlation was found between Smac/DIABLO immunoreactivity and microvascular density, a marker for angiogenesis (p = 0.04). Most importantly, Smac/DIABLO immunoreactivity was associated with a higher rate of local recurrence in squamous cell carcinoma (p = 0.002, log rank test). No association was found between Smac/DIABLO and survival rates.

CONCLUSION:

Smac/DIABLO expression is a potential marker for local recurrence in cervical squamous cell carcinoma patients.

PMID:
17067390
PMCID:
PMC3225885
DOI:
10.1186/1471-2407-6-256
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center